Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Gainers

• ObsEva SA (NASDAQ:OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
• Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares jumped 52.7% to $3.59 after the company said data from a recent peer-reviewed clinical study demonstrated Bentrio's superior nasal residence time and rheological properties.
• Lavoro Limited (NASDAQ:LVRO) gained 44.7% to $13.86. Lavoro and TPB Acquisition Corporation I announced completion of business combination.
• HUB Cyber Security (Israel) Ltd. (NASDAQ:HUBC) rose 36.6% to $1.71 after dipping 21% on Thursday.
• Seer, Inc. (NASDAQ:SEER) gained 35% to $5.68 after the company reported better-than-expected Q4 EPS and sales results.
• ETAO International Co., Ltd. (NASDAQ:ETAO) jumped 33% to $2.0294.
• Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) gained 30.3% to $3.5569. Bullfrog AI recently priced its IPO at $6.50 per share.
• Ardelyx, Inc. (NASDAQ:ARDX) surged 28% to $3.70 after the company reported better-than-expected Q4 sales results.
• C3.ai, Inc. (NYSE:AI) shares jumped 24.3% to $26.48 after the company reported better-than-expected Q3 results and issued strong guidance.
• Genius Group Limited (NYSE:GNS) gained 24.3% to $2.8340.
• Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) gained 23% to $1.39.
• Heritage Insurance Holdings, Inc. (NASDAQ:HRTG) rose 22.2% to $3.3224 after posting Q4 results.
• Samsara Inc. (NYSE:IOT) gained 21.7% to $20.55 after the company reported better-than-expected Q4 results and issued strong guidance.
• Velo3D, Inc. (NYSE:VLD) rose 20.5% to $3.4094 after the company reported better-than-expected Q4 adjusted EPS and sales results.
• Rubius Therapeutics, Inc. (NASDAQ:RUBY) gained 19.8% to $0.1360. Rubius Therapeutics recently outlined dissolution plan, after unsuccessful attempt on alternatives.
• Xos, Inc. (NASDAQ:XOS) jumped 19% to $0.7894.
• Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) gained 19% to $2.5950 after the company reported Q4 financial results.
• Lucy Scientific Discovery Inc. (NASDAQ:LSDI) gained 18.7% to $1.9363.
• Gaotu Techedu Inc. (NYSE:GOTU) surged 17.5% to $5.16.
• Veritone, Inc. (NASDAQ:VERI) rose 16.7% to $7.42 after the company reported Q4 financial results.
• LivePerson, Inc. (NASDAQ:LPSN) jumped 16.2% to $11.19 after Craig-Hallum upgraded the stock from Hold to Buy and raised its price target from $13 to $15.
• Kuke Music Holding Limited (NYSE:KUKE) gained 15.6% to $1.11.
• Impac Mortgage Holdings, Inc. (NYSE:IMH) surged 15.4% to $0.3477.
• DermTech, Inc. (NASDAQ:DMTK) gained 15.3% to $4.38 following strong quarterly results.
• Hillstream BioPharma, Inc. (NASDAQ:HILS) jumped 15% to $1.30.
• Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) gained 14.7% to $0.1751.
• Reading International, Inc. (NASDAQ:RDIB) gained 13.6% to $22.75.
• Genelux Corporation (NASDAQ:GNLX) surged 13.6% to $18.60.
• CEL-SCI Corporation (NYSE:CVM) rose 13.2% to $2.6485.
• Xponential Fitness, Inc. (NYSE:XPOF) surged 12.9% to $28.57 after the company reported better-than-expected Q4 EPS and sales results.
• Compass, Inc. (NYSE:COMP) gained 12.6% to $3.40. Compass recently reported worse-than-expected Q4 results and issued weak Q1 guidance.
• Zai Lab Limited (NASDAQ:ZLAB) rose 12.1% to $41.42.
• HPX Corp. (NYSE:HPX) shares gained 12% to $19.50. The company’s shareholders recently approved the proposed business combination with Emergencia Participacoes.
• TuSimple Holdings Inc. (NASDAQ:TSP) jumped 11.3% to $2.0150.
• PagSeguro Digital Ltd. (NYSE:PAGS) gained 9.9% to $9.31 after reporting a 35% surge in its Q4 net profit.
• BigBear.ai Holdings, Inc. (NYSE:BBAI) shares rose 9.2% to $3.10 after gaining over 8% on Thursday.

Losers

• Praxis Precision Medicines, Inc. (NASDAQ:PRAX) shares dipped 64% to $1.0501 after the company announced topline results from the Essential1 study evaluating the efficacy, safety, and tolerability of ulixacaltamide (PRAX-944) for essential tremor (ET).
• Veru Inc. (NASDAQ:VERU) fell 39% to $2.3050 after the FDA declined to grant the company's request for Emergency Use Authorization for sabizabulin.
• NeuroPace, Inc. (NASDAQ:NPCE) dropped 22.8% to $3.2950 after the company reported Q4 financial results.
• Anghami Inc. (NASDAQ:ANGH) dropped 21.6% to $1.5350.
• Secoo Holding Limited (NASDAQ:SECO) declined 20.5% to $1.16.
• Assure Holdings Corp. (NASDAQ:IONM) fell 20% to $0.2398 after the company announced a 1-for-20 reverse stock split.
• Qilian International Holding Group Limited (NASDAQ:QLI) dropped 17.5% to $1.18
• Biomerica, Inc. (NASDAQ:BMRA) fell 17% to $2.2981. Biomerica raised $8 million via secondary stock offering at $2.40 per share for general corporate purposes.
• Lucira Health, Inc. (NASDAQ:LHDX) dropped 17% to $0.4644.
• CareDx, Inc (NASDAQ:CDNA) fell 15.7% to $9.06. Raymond James and Craig-Hallum downgraded the stock.
• Puma Biotechnology, Inc. (NASDAQ:PBYI) dropped 15.5% to $3.36 after the company reported worse-than-expected Q4 adjusted EPS results.
• Eagle Bulk Shipping Inc. (NYSE:EGLE) fell 15.5% to $55.47 after the company reported worse-than-expected Q4 adjusted EPS results.
• Cidara Therapeutics, Inc. (NASDAQ:CDTX) fell 14.7% to $1.5450 after the company reported pricing of public offerings of common stock and preferred stock.
• Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares fell 13.8% to $8.92. Arcadia Biosciences announced $6 million private placement of 666,334 shares priced at a premium price of $9 per share to market under Nasdaq rules.
• MMTec, Inc. (NASDAQ:MTC) fell 13.8% to $1.80 after surging 32% on Thursday.
• Proterra Inc. (NASDAQ:PTRA) fell 11.5% to $3.6725.
• Viemed Healthcare, Inc. (NASDAQ:VMD) fell 11.2% to $7.99 after the company reported worse-than-expected Q4 sales results.
• Despegar.com, Corp. (NYSE:DESP) dropped 11% to $5.46. Despegar said CFO Alberto Lopez Gaffney tendered his resignation, effective March 17, 2023.
• Zscaler, Inc. (NASDAQ:ZS) shares fell 9.8% to $120.89 despite better-than-expected Q2 results. The company also announced a restructuring plan, which includes a 3% workforce reduction.
• Marvell Technology, Inc. (NASDAQ:MRVL) fell 8.7% to $42.21 after the company reported mixed Q4 results and issued Q1 EPS guidance below estimates.

Now Read This: Top 5 Real Estate Stocks That Are Set To Fly In March